circulating anticoagulants

11/01/1952 - "Hemophilia with two circulating anticoagulants; clinical and experimental study."
01/01/1988 - "[Circulating anticoagulants excluding hemophilia. "
07/01/1973 - "[Circulating anticoagulants in hemophilia A]."
12/01/1972 - "[Circulating anticoagulants during hemophilia]."
09/01/1972 - "[Circulating anticoagulants in hemophilia]."

03/01/1992 - "[Circulating anticoagulants, antiphospholipids and thrombosis]."
09/01/1963 - "THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS."
11/01/1995 - "The tendency for thrombosis in these patients often can be associated with the presence of circulating anticoagulants from a group of antiphospholipid antibodies. "
08/01/1985 - "In an earlier report on the kidney in systemic lupus erythematosus (SLE), we described a subset of patients with circulating anticoagulants; many had glomerular and arteriolar thrombosis in the absence of necrosis and subendothelial deposits. "
03/09/1977 - "It is important to study coagulation during lupus disease, not only to detect circulating anticoagulants, which may be the cause of hemorrhage, but also in order to seek chronic hypercoagulability, which is more dangerous as it may favour the development of thrombosis on inflammatory arteritis or aggravate the development of glomerular lesions. "

11/01/1976 - "Filling defects in the renal pelvis and ureter owing to bleeding secondary to acquired circulating anticoagulants."
08/01/2000 - "I discuss hereditary disorders of platelets and/or coagulation proteins that lead to clinical bleeding as well as acquired disorders, including disseminated intravascular coagulation and acquired circulating anticoagulants."
03/09/1977 - "It is important to study coagulation during lupus disease, not only to detect circulating anticoagulants, which may be the cause of hemorrhage, but also in order to seek chronic hypercoagulability, which is more dangerous as it may favour the development of thrombosis on inflammatory arteritis or aggravate the development of glomerular lesions. "
01/01/1975 - "Four basic coagulation tests, the prothrombin time, thrombin time, partial thromboplastin time, and prothrombin consumption time, were used, with relatively simple modifications, to demonstrate the presence of two circulating anticoagulants in the blood of a patient with IgG myeloma and a severe bleeding tendency."
01/01/2002 - "Recombinant activated factor VII (rFVIIa, NovoSeven, Novo Nordisk A/S, Denmark) is a treatment used to prevent and arrest intra- and postoperative bleeding in patients with haemophilia A or B complicated by circulating anticoagulants (inhibitors of FVIII and FIX) and in patients without haemophilia who spontaneously develop inhibitors of FVIII, i.e. "

07/01/1973 - "Circulating anticoagulants in the newborn: relation to hypercoagulability and the idiopathic respiratory distress syndrome."
03/09/1977 - "It is important to study coagulation during lupus disease, not only to detect circulating anticoagulants, which may be the cause of hemorrhage, but also in order to seek chronic hypercoagulability, which is more dangerous as it may favour the development of thrombosis on inflammatory arteritis or aggravate the development of glomerular lesions. "
01/01/2010 - "Hypercoagulability, changes in coagulation factors, anticoagulant proteins, circulating anticoagulants or platelets, and vascular responses have been noted during the disease process. "
01/01/2009 - "Drug-induced syndromes include hemolytic anemias, methemoglobinemia, red cell aplasia, sideroblastic anemia, megaloblastic anemia, polycythemia, aplastic anemia, leukocytosis, neutropenia, eosinophilia, immune thrombocytopenia, microangiopathic syndromes, hypercoagulability, hypoprothrombinemia, circulating anticoagulants, myelodysplasia, and acute leukemia. "

03/01/1959 - "[Study of the laboratory techniques permitting the differential diagnosis of hemorrhagic diathesis; methods for differentiating the types of hemophilia and for detecting the presence of circulating anticoagulants]."
04/30/1956 - "[Hemorrhagic diathesis caused by heparinoid type of circulating anticoagulants]."